Analysis reveals device eligibility for endovascular repair in patients post-aortic dissection, indicating potential surgical improvements.
Approximately half of patients with residual aortic arch pathology after ATAAD surgery are eligible for Ar-TEVAR with Nexus and RelayBranch systems. Surgically modifiable factors at the time of the index procedure frequently contribute to ineligibility, highlighting the need for surgical strategies that optimize future endovascular options.
No takes yet. Share an insight, caveat, or question.
D'Onofrio et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: